BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2461495)

  • 21. [Excretion of free and bound catecholamines in the urine in ischemic heart disease].
    Orbetsova V; Orbetsov M; Beloev I; Dakovska L; Mikhaĭlova M
    Vutr Boles; 1978; 17(5):63-72. PubMed ID: 716373
    [No Abstract]   [Full Text] [Related]  

  • 22. [Qualitative analysis of the main urinary metabolites of dopamine, epinephrine and norepinephrine by gas chromatography].
    Bègue RJ; Bazerolle O; Desgres J; Lallemant C; Padieu P
    Pathol Biol (Paris); 1971; 19(15):719-25. PubMed ID: 4942503
    [No Abstract]   [Full Text] [Related]  

  • 23. [Dopamine and dopa as indices of reserve potential of the sympatho-adrenal system in pulmonary heart].
    Syvomiatnikova NV; Mel'nikova TO; Goncharova VA
    Ter Arkh; 1972 May; 44(5):94-6. PubMed ID: 5069087
    [No Abstract]   [Full Text] [Related]  

  • 24. [Excretion of catecholamines and their precursors with the urine in patients with infectious nonspecific (rheumatoid) polyarthritis].
    Frenkel' ID; Kalandarov SK; Fiveĭskaia AA
    Ter Arkh; 1969 Sep; 41(9):40-3. PubMed ID: 5396447
    [No Abstract]   [Full Text] [Related]  

  • 25. [Urinary excretion of catecholamines and their precursors in hypotensive patients].
    Frenkel' ID; Kalandarov SK; Studnitsina LA
    Kardiologiia; 1968 Jul; 8(7):71-3. PubMed ID: 5697488
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of reserpine on catecholamine metabolism and behavior in retarded children.
    Anton AH
    Clin Pharmacol Ther; 1966; 7(6):727-39. PubMed ID: 5918009
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of a test with 0.1 g of L-DOPA on the dynamics of urinary excretion of catecholamines and DOPA in schizophrenic patients].
    Vasil'ev VN
    Vopr Med Khim; 1980; 26(6):782-6. PubMed ID: 6779421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Changes in the levels of adrenergic and serotoninergic indices in patients with depressive states].
    Misionzhnik EIu; Vertogradova OP; Krasnov VN; Salenko BB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(4):543-51. PubMed ID: 6168150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Reactivity of the DOPA--dopamine--noradrenaline--adrenaline system in epileptics].
    Karlov VA; Gleĭzer MA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(6):810-5. PubMed ID: 6410626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopa, catecholamines and their metabolites in essential hypertension.
    Januszewicz W; Wocial B
    Clin Sci Mol Med Suppl; 1975 Jun; 2():295s-298s. PubMed ID: 1077780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proceedings: Effect of amantadine on the urinary excretion of some monoamines and metabolites in normal and parkinsonian subjects.
    Jones DG; Lenman JA; Robertson MA; Turnbull MJ
    Br J Pharmacol; 1972 Feb; 44(2):386P-387P. PubMed ID: 4668639
    [No Abstract]   [Full Text] [Related]  

  • 32. [Urinary excretion of catecholamines and their precursors in myocardial infarct].
    Berezkin SE; Tarasov AN
    Vrach Delo; 1981 Oct; (10):10-3. PubMed ID: 6795819
    [No Abstract]   [Full Text] [Related]  

  • 33. [Evaluation of the usefulness for measuring catecholamines and their principle metabolites in the diagnosis of pheochromocytoma].
    Wocial B; Januszewicz W; Gryglas P; Januszewicz A; Feltynowski T; Lapiński M
    Przegl Lek; 1997; 54(11):793-8. PubMed ID: 9501691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Catecholamine metabolism in manic-depressive psychosis].
    Usherenko LS
    Fiziol Zh; 1970; 16(3):393-9. PubMed ID: 5509683
    [No Abstract]   [Full Text] [Related]  

  • 35. [Excretion of catecholamines and their precursors during nighttime and daytime work].
    Matlina ESh; Vasil'ev VN; Brodskaia TV
    Fiziol Zh SSSR Im I M Sechenova; 1971 Jul; 57(7):1027-31. PubMed ID: 5565019
    [No Abstract]   [Full Text] [Related]  

  • 36. Reactivity of the dopa-dopamine-noradrenaline-adrenaline system in epileptic patients.
    Karlov VA; Gleiser MA
    Neurosci Behav Physiol; 1986; 16(1):49-53. PubMed ID: 3090474
    [No Abstract]   [Full Text] [Related]  

  • 37. [Catecholamine excretion in torsion dystonia].
    Barkatova VP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(4):495-503. PubMed ID: 654723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of amantadine on the urinary excretion of some monoamines and metabolites in normal and Parkinsonian subjects.
    Jones DG; Turnbull MJ; Lenman JA; Robertson MA
    J Neurol Sci; 1972 Nov; 17(3):245-53. PubMed ID: 4653961
    [No Abstract]   [Full Text] [Related]  

  • 39. The "switch process" in manic-depressive illness. II. Relationship to catecholamines, REM sleep, and drugs.
    Bunney WE; Goodwin FK; Murphy DL; House KM; Gordon EK
    Arch Gen Psychiatry; 1972 Sep; 27(3):304-9. PubMed ID: 4340658
    [No Abstract]   [Full Text] [Related]  

  • 40. [Various features of dopamine metabolism in schizophrenia].
    Anokhina IP; Kogan BM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(9):1343-7. PubMed ID: 6798791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.